Sanderson RD - Search Results

1

Heparanase-enhanced Shedding of Syndecan-1 and Its Role in Driving Disease Pathogenesis and Progression.

Rangarajan S, Richter JR, Richter RP, Bandari SK, Tripathi K, Vlodavsky I, Sanderson RD. Rangarajan S, et al. Among authors: sanderson rd. J Histochem Cytochem. 2020 Dec;68(12):823-840. doi: 10.1369/0022155420937087. Epub 2020 Jul 6. J Histochem Cytochem. 2020. PMID: 32623935 Free PMC article. Review.

2

Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis.

Yang Y, Macleod V, Miao HQ, Theus A, Zhan F, Shaughnessy JD Jr, Sawyer J, Li JP, Zcharia E, Vlodavsky I, Sanderson RD. Yang Y, et al. Among authors: sanderson rd. J Biol Chem. 2007 May 4;282(18):13326-33. doi: 10.1074/jbc.M611259200. Epub 2007 Mar 8. J Biol Chem. 2007. PMID: 17347152 Free article.

3

The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy.

Yang Y, MacLeod V, Dai Y, Khotskaya-Sample Y, Shriver Z, Venkataraman G, Sasisekharan R, Naggi A, Torri G, Casu B, Vlodavsky I, Suva LJ, Epstein J, Yaccoby S, Shaughnessy JD Jr, Barlogie B, Sanderson RD. Yang Y, et al. Among authors: sanderson rd. Blood. 2007 Sep 15;110(6):2041-8. doi: 10.1182/blood-2007-04-082495. Epub 2007 May 29. Blood. 2007. PMID: 17536013 Free PMC article.

4

Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma.

Purushothaman A, Chen L, Yang Y, Sanderson RD. Purushothaman A, et al. Among authors: sanderson rd. J Biol Chem. 2008 Nov 21;283(47):32628-36. doi: 10.1074/jbc.M806266200. Epub 2008 Sep 23. J Biol Chem. 2008. PMID: 18812315 Free PMC article.

5

Non-anticoagulant heparins and inhibition of cancer.

Casu B, Vlodavsky I, Sanderson RD. Casu B, et al. Among authors: sanderson rd. Pathophysiol Haemost Thromb. 2008;36(3-4):195-203. doi: 10.1159/000175157. Epub 2009 Jan 27. Pathophysiol Haemost Thromb. 2008. PMID: 19176992 Free PMC article. Review.

6

Heparanase regulates levels of syndecan-1 in the nucleus.

Chen L, Sanderson RD. Chen L, et al. Among authors: sanderson rd. PLoS One. 2009;4(3):e4947. doi: 10.1371/journal.pone.0004947. Epub 2009 Mar 23. PLoS One. 2009. PMID: 19305494 Free PMC article.

7

Syndecan-1 is required for robust growth, vascularization, and metastasis of myeloma tumors in vivo.

Khotskaya YB, Dai Y, Ritchie JP, MacLeod V, Yang Y, Zinn K, Sanderson RD. Khotskaya YB, et al. Among authors: sanderson rd. J Biol Chem. 2009 Sep 18;284(38):26085-95. doi: 10.1074/jbc.M109.018473. Epub 2009 Jul 13. J Biol Chem. 2009. PMID: 19596856 Free PMC article.

8

Heparanase: busy at the cell surface.

Fux L, Ilan N, Sanderson RD, Vlodavsky I. Fux L, et al. Among authors: sanderson rd. Trends Biochem Sci. 2009 Oct;34(10):511-9. doi: 10.1016/j.tibs.2009.06.005. Epub 2009 Sep 3. Trends Biochem Sci. 2009. PMID: 19733083 Free PMC article. Review.

9

Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis.

Purushothaman A, Uyama T, Kobayashi F, Yamada S, Sugahara K, Rapraeger AC, Sanderson RD. Purushothaman A, et al. Among authors: sanderson rd. Blood. 2010 Mar 25;115(12):2449-57. doi: 10.1182/blood-2009-07-234757. Epub 2010 Jan 22. Blood. 2010. PMID: 20097882 Free PMC article.

10

Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.

Barash U, Cohen-Kaplan V, Dowek I, Sanderson RD, Ilan N, Vlodavsky I. Barash U, et al. Among authors: sanderson rd. FEBS J. 2010 Oct;277(19):3890-903. doi: 10.1111/j.1742-4658.2010.07799.x. Epub 2010 Aug 31. FEBS J. 2010. PMID: 20840586 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page